Chemical Compound Review:
Dilzem [(4R,5R)-2-(2- dimethylaminoethyl)-5-(4...
Synonyms:
Altiazem, Deltazen, Dilatame, Diltelan, Tiazac, ...
This record was replaced with 39186.
- Anti-ischaemic therapy during the follow-up phase of acute coronary syndromes. Is there a role for calcium channel blockers? Boden, W.E. Drugs (1996)
- A new extended-release formulation of diltiazem HCl for the treatment of mild-to-moderate hypertension. Frishman, W.H. Journal of clinical pharmacology. (1993)
- Effect of morning versus evening dosing of diltiazem on myocardial ischemia detected by ambulatory electrocardiographic monitoring in chronic stable angina pectoris. Dilacor XR Ambulatory Ischemia Study Group. Deedwania, P.C., Pool, P.E., Thadani, U., Eff, J. Am. J. Cardiol. (1997)
- Diltiazem-associated photodistributed hyperpigmentation: a review of 4 cases. Scherschun, L., Lee, M.W., Lim, H.W. Archives of dermatology. (2001)
- Changes in cerebral blood flow accompanied with reduction of blood pressure treatment in patients with hypertensive intracerebral hemorrhages. Kuroda, K., Kuwata, N., Sato, N., Funayama, M., Yabuta, A., Taguchi, S., Suzuki, M., Takahashi, A., Ogawa, A. Neurol. Res. (1997)
- Ca(2+)-channel blockers and nucleoside triphosphate diphosphohydrolase (NTPDase) influence of diltiazem, nifedipine, and verapamil. Gendron, F.P., Latour, J.G., Gravel, D., Wang, Y., Beaudoin, A.R. Biochem. Pharmacol. (2000)
- Effects of benzothiazepine derivative (CRD-401) on blood pressure, excretion of electrolytes, and plasma renin activity. Funyu, T., Nigawara, K., Ohno, K., Hamada, W., Yagihashi, Y. Clinical therapeutics. (1981)
- An evaluation of the effectiveness of the Opportunities for Resuscitation and Citizen Safety (ORCS) defibrillator training programme designed for older school children. Younas, S., Raynes, A., Morton, S., Mackway-Jones, K. Resuscitation. (2006)
- Pharmacokinetics and bioavailability of a sustained-release diltiazem formulation (Mono-Tildiem LP 300 MG) after repeated administration in healthy volunteers. Bianchetti, G., Dubruc, C., Sultana, V., Houin, G., Rosenzweig, P. Eur. J. Clin. Pharmacol. (1995)
- Bioinequivalence of marketed diltiazem preparations. Joshi, M.V., Gokhale, P.C., Pohujani, S.M., Dalvi, S.S., Karandikar, S.M., Kshirsagar, N.A. Eur. J. Clin. Pharmacol. (1990)
- Comparative pharmacokinetics and pharmacodynamics of two marketed bid formulations of diltiazem in healthy volunteers. Guimont, S., Landriault, H., Klischer, K., Grace, M., Lambert, C., Caillé, G., Gossard, D., Russell, A., Raymond, M., Hutchings, E. Biopharmaceutics & drug disposition. (1993)
- Single-dose and steady-state pharmacokinetics of diltiazem administered in two different tablet formulations. Christrup, L.L., Bonde, J., Rasmussen, S.N., Sonnergaard, J.M., Jensen, B.H. Pharmacol. Toxicol. (1992)
- Arctic telehealth: north to the future. Hild, C. International journal of circumpolar health. (2004)
- Effects of diltiazem Hydrochloride (CRD-401) on renal hemodynamics of dogs. Ishikawa, H., Matsushima, M., Matsui, H., Honjo, A., Hayashi, M., Shindo, T., Morifuji, T., Okaybayashi, M. Arzneimittel-Forschung. (1978)
- Effects of diltiazem hydrochloride (CRD-401) on hepatic, superior mesenteric and femoral hemodynamics. Ishikawa, H., Matsushima, A., Matsui, H., Shindo, T., Morifuji, T., Okabayashi, M. Arzneimittel-Forschung. (1978)
- A pitfall of the diagnostic process of differentiating bile peritonitis from acute appendicitis. Moriwaki, Y., Sugiyama, M., Mochizuki, Y., Yamazaki, Y., Suda, T., Hasegawa, S., Matsuda, G., Karube, N., Uchida, K., Yamamoto, T. Hepatogastroenterology (2004)
- Steady-state pharmacokinetics of high-dose diltiazem hydrochloride (Cardizem CD) administered once daily in healthy volunteers. Robbins-Weilert, D.K., Giesing, D.H., Weir, S.J. American journal of therapeutics. (1999)
- Home care delivery through the mobile telecommunications platform: the Citizen Health System (CHS) perspective. Maglaveras, N., Koutkias, V., Chouvarda, I., Goulis, D.G., Avramides, A., Adamidis, D., Louridas, G., Balas, E.A. International journal of medical informatics. (2002)
- Comparison of diltiazem bioavailability from 3 marketed extended-release products for once-daily administration: implications of chronopharmacokinetics and dynamics. Eradiri, O., Midha, K.K. International journal of clinical pharmacology and therapeutics. (1997)
- The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (Diabetes and Combined Lipid Therapy Regimen) study. Muhlestein, J.B., May, H.T., Jensen, J.R., Horne, B.D., Lanman, R.B., Lavasani, F., Wolfert, R.L., Pearson, R.R., Yannicelli, H.D., Anderson, J.L. J. Am. Coll. Cardiol. (2006)
- Comparative bioavailability of two tablet preparations of diltiazem in healthy volunteers. De Bernardis, E., Candido, P., Lorefice, R., Picari, M., Rizza, V. Arzneimittel-Forschung. (1992)
- Guar gum-based sustained release diltiazem. Altaf, S.A., Yu, K., Parasrampuria, J., Friend, D.R. Pharm. Res. (1998)
- Preparation of Novel Cationic Copolymer Microspheres and Evaluation of Their Function by In Vitro and In Vivo tests as Ph-Sensitive Drug Carrier Systems. Sun, C., Liu, H., Zhang, S., Li, X., Pan, W. Drug development and industrial pharmacy. (2006)
- Evaluating the impact of a conference. Gombeski, W.R., Farge, E.J., Ramirez, A.G., Moore, T.J., Freyer, B.S., Weaver, F.J. Health matrix. (1984)